SLNO logo

SLNO

Soleno Therapeutics, Inc.NASDAQHealthcare
$39.49+32.31%ClosedMarket Cap: $2.12B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-18OppenheimermaintainOutperformOutperform
2026-03-04HC Wainwright & Co.maintainBuyBuy
2026-02-27Wells FargomaintainOverweightOverweight
2026-02-26TD CowenmaintainBuyBuy
2026-01-20HC Wainwright & Co.maintainBuyBuy
2026-01-20Wells FargomaintainOverweightOverweight
2025-11-05Wells FargomaintainOverweightOverweight
2025-08-27GuggenheimmaintainBuyBuy
2025-08-18HC Wainwright & Co.maintainBuyBuy
2025-08-07OppenheimermaintainOutperformOutperform
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$6.56$721.6M9
Sun Dec 31$9.18$1.00B7
Mon Dec 31$12.81$1.35B2
Tue Dec 31$16.04$1.64B5